Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,218,364
-$591,418 QoQ
Shares Held
133,653
-1.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#775
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. PFE ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
This page
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,324 | $2,946,754 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,218,364 | 133,653 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,809,782 | 135,676 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,291,705 | 132,197 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,468,057 | 136,109 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,245,057 | 133,872 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,273,953 | 129,201 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $3,314,021 | 124,916 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,588,617 | 124,002 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,413,196 | 121,987 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,361,468 | 121,134 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,478,119 | 120,810 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,877,772 | 116,906 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,126,500 | 112,500 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,551,770 | 111,563 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $5,913,608 | 115,410 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,803,972 | 109,780 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,551,235 | 105,879 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,554,662 | 107,295 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $6,236,979 | 105,622 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,475,878 | 104,066 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,006,498 | 102,311 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,681,221 | 101,607 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,592,067 | 97,584 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,934,566 | 107,209 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,867,204 | 87,682 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $3,485,163 | 106,776 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||